Amber Watts still remembers the first brain scan that made her pause—a swirl of red and green lighting up the cortex of a 72-year-old woman who had used hormonal birth control in her twenties and hormone therapy in her fifties. That image, part of a study of 459 women aged 65 to 80 at the University of Kansas, is now helping reshape how scientists think about estrogen, brain health, and aging in women. For decades, estrogen was seen primarily as a reproductive hormone, but Watts and her team are showing it may also be a quiet guardian of the aging brain.
Their findings, published in NeuroImage, reveal that estrogen exposure—whether through birth control, menopausal hormone therapy (MHT), or a later age at natural menopause—is linked to stronger, healthier brains in later life. Women who used hormonal birth control in early adulthood showed larger brain volumes in regions tied to memory and cognition. Even more striking, those who underwent MHT during menopause showed similar benefits, suggesting a lifetime of estrogen exposure may build a kind of neural resilience. This matters deeply: women make up nearly two-thirds of all Alzheimer’s cases in the U.S., according to the Alzheimer’s Association, and understanding protective factors could be key to reducing that disparity.
The data paints a compelling picture. Women who started menopause later—meaning their bodies produced natural ovarian hormones for more years—had a thicker cortex in brain areas vulnerable to Alzheimer’s, including the left middle occipital gyrus. The study examined 459 women, tracking not just medical histories but actual brain structure through MRI scans. Watts emphasizes that it’s not just one source of estrogen that counts. “What’s unique about this paper is we looked at the use of hormone-based medications both in early adulthood and in midlife, and the use of both of those was associated with brain health in older adult women,” she said.
Estrogen, it turns out, does far more than regulate reproduction. It supports white matter integrity, strengthens neural connections, and promotes vascular health. “Estrogen is neuroprotective,” Watts said. “It’s important for the brain, it’s important for the heart, it’s important for bone density, and it’s important for the immune system.” This broader understanding is helping correct fears sparked by the controversial 2002 Women’s Health Initiative study, which wrongly painted hormone therapy as universally risky. Newer research, including Watts’ work, suggests timing and context matter—especially when it comes to brain health.
The implications are profound. With about 65% of American women of childbearing age using hormonal birth control, according to the CDC, these findings invite a shift in how we view reproductive choices—not just as decisions about fertility, but as potential investments in long-term cognitive well-being. As Watts and her colleagues continue to map the connections between hormones and brain aging, one message is clear: estrogen may be one of the brain’s quietest, yet most powerful, allies.